Signifor Lar 30 mg (Pasireotide (Pasireotide Pamoate) KIT) 30 MG

Signifor LAR 30 mg is a medication used for managing certain hormonal conditions. This intramuscular kit contains pasireotide pamoteate, a somatostatin analog, and is prescribed for specific therapeutic uses.

Strength

30 MG

Manufacturer / TM Owner

RECORDATI RARE DISEASES CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Signifor LAR 30 mg is primarily used to manage symptoms associated with hormonal imbalances. It is often prescribed for conditions where excess hormone production occurs, such as Cushing's disease. Patients may wonder, 'What is Signifor LAR used for?' It is designed to help regulate hormone levels and alleviate related symptoms.

Side Effects

Common effects of Signifor LAR 30 mg may include gastrointestinal discomfort, such as nausea or diarrhea. Some users might experience changes in blood sugar levels or fatigue. These effects can vary among individuals and are not exhaustive.

Precautions & Warnings

Signifor LAR 30 mg should be handled with care, following the instructions provided by a healthcare professional. It is important to store the medication properly and use it as directed. Patients should be aware of potential side effects and discuss any concerns with their healthcare provider.

Avoid Interactions

Signifor LAR 30 mg may interact with other medications, including those that affect blood sugar levels or gastrointestinal function. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.

Frequently Asked Questions

Signifor LAR 30 mg is used to manage symptoms associated with hormonal imbalances, such as those seen in Cushing's disease.

Signifor LAR 30 mg is administered intramuscularly, typically by a healthcare professional.

Common side effects may include gastrointestinal discomfort, changes in blood sugar levels, and fatigue.

Signifor LAR 30 mg may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Signifor LAR 30 mg should be stored according to the instructions provided by the manufacturer to maintain its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.